Clinical Trials Directory

Trials / Completed

CompletedNCT03836144

Effect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With Cystinuria

Effect of Urine Alkalinazation on Urinary Inflammatory Markers Analyzed Using Mass Spectrometry in Patients With Cystinuria

Status
Completed
Phase
Study type
Observational
Enrollment
63 (actual)
Sponsor
European Georges Pompidou Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

It has recently been described the presence of a urinary inflammatory signature in patients with cystinuria, the most common cause of renal lithiasis of genetical origin. These data are very innovative in this pathology but deserve further studies to establish the specificity of this inflammatory signature in patients with cystinuria compared to other nephropathies and other renal lithiasis diseases. Moreover, the effect of the usual treatment of cystinuria (namely urine alkalanization) on urinary inflammatory biomarkers deserves to be tested. The objectives of the present study are: i) To study the urinary inflammatory profile by mass spectrometry (a very efficient tool to detect and identify proteins) in patients with cystinuria and in patients with lithiasis of other origin and in patients with inflammatory renal disease ; ii) To study the potential effect of urine alkalinazation with potassium citrate (usual treatment according to European recommendations) on the inflammatory signature of patients with cystinuria. To this aim, urine of non treated cystinuric patients will be collected before treatement initiation and 3 months after the start of the alkalizing treatment.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPotassium citrate

Timeline

Start date
2015-04-02
Primary completion
2020-01-31
Completion
2020-12-31
First posted
2019-02-11
Last updated
2022-03-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03836144. Inclusion in this directory is not an endorsement.